Literature DB >> 7889973

Isolation of Vero cytotoxin-producing Escherichia coli serotypes O9ab:H- and O101:H-carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome.

A Thomas1, T Cheasty, H Chart, B Rowe.   

Abstract

Vero cytotoxin-producing Escherichia coli (VTEC) were isolated from the faecal specimen of a patient with haemolytic uraemic syndrome. The isolates belonged to two rare VTEC serotypes, O9ab:H- and O101:H-. Polymerase chain reaction gene amplification products were detected with primers specific for the VT2e gene, a variant of VT2. The toxin from both isolates was cytotoxic to Vero cells but not to HeLa cells. An 18 kb EcoRI restriction enzyme fragment of genomic DNA from both strains hybridised with a VT2 polynucleotide DNA probe.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889973     DOI: 10.1007/bf02111832

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant.

Authors:  A Thomas; H R Smith; G A Willshaw; B Rowe
Journal:  Mol Cell Probes       Date:  1991-04       Impact factor: 2.365

2.  Isolation of verotoxin-producing Escherichia coli from slaughtered pigs.

Authors:  A Caprioli; A Nigrelli; R Gatti; M Zavanella
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-03       Impact factor: 3.267

3.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.

Authors:  D L Weinstein; M P Jackson; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

4.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Authors:  H Kleanthous; H R Smith; S M Scotland; R J Gross; B Rowe; C M Taylor; D V Milford
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

5.  Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family.

Authors:  V P Gannon; C Teerling; S A Masri; C L Gyles
Journal:  J Gen Microbiol       Date:  1990-06

6.  Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome.

Authors:  H Ito; A Terai; H Kurazono; Y Takeda; M Nishibuchi
Journal:  Microb Pathog       Date:  1990-01       Impact factor: 3.738

7.  Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes.

Authors:  G A Willshaw; H R Smith; S M Scotland; A M Field; B Rowe
Journal:  J Gen Microbiol       Date:  1987-05

8.  Examination of retail chickens and sausages in Britain for vero cytotoxin-producing Escherichia coli.

Authors:  H R Smith; T Cheasty; D Roberts; A Thomas; B Rowe
Journal:  Appl Environ Microbiol       Date:  1991-07       Impact factor: 4.792

Review 9.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

10.  Nine DNA probes for detection of toxin and adhesin genes in Escherichia coli isolated from diarrhoeal disease in animals.

Authors:  M J Woodward; C Wray
Journal:  Vet Microbiol       Date:  1990-10       Impact factor: 3.293

View more
  29 in total

1.  Shiga toxin-producing Escherichia coli O100:H⁻: stx2e in drinking water contaminated by waste water in Finland.

Authors:  Taru Lienemann; Tarja Pitkänen; Jenni Antikainen; Elina Mölsä; Ilkka Miettinen; Kaisa Haukka; Martti Vaara; Anja Siitonen
Journal:  Curr Microbiol       Date:  2010-12-25       Impact factor: 2.188

2.  Distribution of the saa gene in strains of Shiga toxin-producing Escherichia coli of human and bovine origins.

Authors:  Claire Jenkins; Neil T Perry; Tom Cheasty; Darren J Shaw; Gad Frankel; Gordon Dougan; George J Gunn; Henry R Smith; Adrienne W Paton; James C Paton
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.

Authors:  Abhineet S Sheoran; Susan Chapman-Bonofiglio; Barrett R Harvey; Jean Mukherjee; George Georgiou; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Prevalence and clinical manifestations of Shiga toxin-producing Escherichia coli infections in Austrian children.

Authors:  F Allerberger; D Rossboth; M P Dierich; S Aleksic; H Schmidt; H Karch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

5.  Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4.

Authors:  A Thomas; T Cheasty; J A Frost; H Chart; H R Smith; B Rowe
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

6.  Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells.

Authors:  Anne-Katharina Sonntag; Martina Bielaszewska; Alexander Mellmann; Nadine Dierksen; Peter Schierack; Lothar H Wieler; M Alexander Schmidt; Helge Karch
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

Review 7.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Prevalence and characterization of shiga toxin-producing Escherichia coli in swine feces recovered in the National Animal Health Monitoring System's Swine 2000 study.

Authors:  Pina M Fratamico; Lori K Bagi; Eric J Bush; Barbara T Solow
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

9.  Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli.

Authors:  M A Karmali; M Petric; M Bielaszewska
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

10.  Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin.

Authors:  S Franke; D Harmsen; A Caprioli; D Pierard; L H Wieler; H Karch
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.